| Ethical and safety issues of stem cell-based therapy V Volarevic, BS Markovic, M Gazdic, A Volarevic, N Jovicic, N Arsenijevic, ... International journal of medical sciences 15 (1), 36, 2018 | 699 | 2018 |
| Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases CR Harrell, N Jovicic, V Djonov, N Arsenijevic, V Volarevic Cells 8 (12), 1605, 2019 | 553 | 2019 |
| Analysis of cycloheximide‐induced apoptosis in human leukocytes: Fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide D Baskić, S Popović, P Ristić, NN Arsenijević Cell biology international 30 (11), 924-932, 2006 | 547 | 2006 |
| Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome CR Harrell, C Fellabaum, N Jovicic, V Djonov, N Arsenijevic, V Volarevic Cells 8 (5), 467, 2019 | 414 | 2019 |
| Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus V Volarevic, N Arsenijevic, ML Lukic, M Stojkovic Stem cells 29 (1), 5-10, 2011 | 359 | 2011 |
| Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity V Volarevic, B Djokovic, MG Jankovic, CR Harrell, C Fellabaum, V Djonov, ... Journal of biomedical science 26, 1-14, 2019 | 357 | 2019 |
| Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells IP Jovanovic, NN Pejnovic, GD Radosavljevic, JM Pantic, MZ Milovanovic, ... International journal of cancer 134 (7), 1669-1682, 2014 | 351 | 2014 |
| IL-33/ST2 axis in inflammation and immunopathology M Milovanovic, V Volarevic, G Radosavljevic, I Jovanovic, N Pejnovic, ... Immunologic research 52, 89-99, 2012 | 335 | 2012 |
| Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis V Volarevic, J Nurkovic, N Arsenijevic, M Stojkovic Stem cells 32 (11), 2818-2823, 2014 | 289 | 2014 |
| Mesenchymal stem cells: a friend or foe in immune-mediated diseases M Gazdic, V Volarevic, N Arsenijevic, M Stojkovic Stem Cell Reviews and Reports 11, 280-287, 2015 | 248 | 2015 |
| Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis V Volarevic, A Al-Qahtani, N Arsenijevic, S Pajovic, ML Lukic Autoimmunity 43 (4), 255-263, 2010 | 227 | 2010 |
| Mesenchymal stem cell‐based therapy of inflammatory lung diseases: current understanding and future perspectives CR Harrell, R Sadikot, J Pascual, C Fellabaum, MG Jankovic, N Jovicic, ... Stem cells international 2019 (1), 4236973, 2019 | 199 | 2019 |
| Galectin-3 deficiency accelerates high-fat diet–induced obesity and amplifies inflammation in adipose tissue and pancreatic islets NN Pejnovic, JM Pantic, IP Jovanovic, GD Radosavljevic, MZ Milovanovic, ... Diabetes 62 (6), 1932-1944, 2013 | 196 | 2013 |
| Protective role of IL-33/ST2 axis in Con A-induced hepatitis V Volarevic, M Mitrovic, M Milovanovic, I Zelen, I Nikolic, S Mitrovic, ... Journal of hepatology 56 (1), 26-33, 2012 | 191 | 2012 |
| Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential V Volarevic, M Gazdic, B Simovic Markovic, N Jovicic, V Djonov, ... Biofactors 43 (5), 633-644, 2017 | 178 | 2017 |
| ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma I Jovanovic, G Radosavljevic, M Mitrovic, V Lisnic Juranic, ANJ McKenzie, ... European journal of immunology 41 (7), 1902-1912, 2011 | 177 | 2011 |
| Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse M Borovcanin, I Jovanovic, G Radosavljevic, SD Dejanovic, D Bankovic, ... Journal of psychiatric research 46 (11), 1421-1426, 2012 | 176 | 2012 |
| The roles of Galectin-3 in autoimmunity and tumor progression G Radosavljevic, V Volarevic, I Jovanovic, M Milovanovic, N Pejnovic, ... Immunologic research 52, 100-110, 2012 | 165 | 2012 |
| Interleukin-17 in chronic inflammatory neurological diseases J Milovanovic, A Arsenijevic, B Stojanovic, T Kanjevac, D Arsenijevic, ... Frontiers in immunology 11, 947, 2020 | 164 | 2020 |
| Galectin‐3 deficiency prevents concanavalin A–induced hepatitis in mice V Volarevic, M Milovanovic, B Ljujic, N Pejnovic, N Arsenijevic, U Nilsson, ... Hepatology 55 (6), 1954-1964, 2012 | 141 | 2012 |
Nemanja JovicicFaculty of Medical Sciences, University of Kragujevac在 medf.kg.ac.rs 的电子邮件经过验证
